Join AZBio’s Board of Directors and Arizona’s Bioscience and Healthcare Community for the AZBio Barbecue at Pinnacle Transplant Technologies on April 25, 2019. Register Today!  

 AZBio Member News

Autism symptoms reduced nearly 50% two years after fecal transplant

Recent research suggests our gut microbiomes affect brain communication and neurological health. Worldwide, interest is growing in the idea that changes in normal gut microbiota may be responsible for triggering various conditions. At ASU, a research team is exploring using the microbiome to treat autism symptoms.

Researchers discover critical RNA processing aberrations

Research by a Barrow Neurological Center scientist on mechanisms of dysfunctional RNA processing in ALS and frontaltemporal dementia (FTD) was published in the April issue of Acta Neuropathologica. The research was conducted by Dr. Rita Sattler and her graduate student Stephen Moore in her laboratory at the Department of Neurobiology at Barrow Neurological Institute, which is dedicated to understanding the mechanisms of disease in ALS, FTD and related neurodegenerative diseases.

Beuses’ $10 million gift to build world’s first-of-its-kind X-ray laser lab at ASU

Investment to advance drug discovery, medicine and renewable energy

HonorHealth Research Institute launches study to research benefit to patients at high risk of bleeding after coronary stent implantation

HonorHealth Research Institute announced that the first patients have been enrolled in the SynIVUS-DAPT Study, a clinical study designed to test outcomes of decreasing the amount of time patients, with a high risk of bleeding, take antiplatelet medications after receiving a drug-eluting coronary stent.

Flinn Foundation Selects 20 Excelling Arizona High-School Seniors as 2019 Flinn Scholars

Twenty of Arizona’s highest-achieving high-school seniors have been named Flinn Scholars and will receive scholarships to Arizona’s three public research universities valued at more than $120,000.

INSYS Therapeutics Implements Leadership Changes

PHOENIX, April 15, 2019 — INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced that the Board of Directors has appointed Andrew G. Long as Chief Executive Officer, effective immediately. Mr. Long succeeds Saeed Motahari, who has mutually agreed with the INSYS Board of Directors to resign as President and CEO of the Company.

bioSyntagma Named Finalist for Global Sustainability Award

Phoenix, Arizona: bioSyntagma has been named a finalist for the competitive Katerva Awards, which recognize disruptive innovations in global sustainability. This comes after bioSyntagma’s recent debut of their mPrint Mind™, an artificial intelligence for screening cancer patients.

Opportunity Alerts

BIO 2019 – It Starts with One 

Jun 3 – 6 , 2019 – Philadelphia

Partnering is now open.  Sign up and start requesting meetings today today.

RESI Philadelphia 

Jun 3, 2019 – Philadelphia
Specifically for early stage companies, RESI’s speed networking format is a great  way to make connections.  AZBio Members save $100 on registration with code.

Click here to learn more  (Application Deadline is May 31st)

Applications for the Student Discovery Zone are now open. 

Click here to submit your poster abstract

Tell Your Story and Show your Support for Arizona’s Bioindustry

Click here to reserve your page in the AZBio Special Supplement in the September/October issue of AzBusiness Magazine

Ad reservation deadline is August 1st.

JOBS

Events  – Committees – Savings

Each session, AZBio reviews all of the bills being considered by the Arizona Legislature and identifies the ones with impact on our industry.  These bills are then tracked on the AZBio Watch List.  Status on bills is updated weekly.  

Click here to access the AZBio Watch List

Save the date: AZBio Government Affairs Call: 

Thursday, May 9th at 3 PM  AZ/PDT

All AZBio Members are welcome to join the AZBio Government Affairs Committee.  Click here to be added to the committee